4//SEC Filing
Trimarchi Thomas 4
Accession 0000950170-25-110274
CIK 0001743881other
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 7:40 PM ET
Size
8.7 KB
Accession
0000950170-25-110274
Insider Transaction Report
Form 4
Trimarchi Thomas
President and COO
Transactions
- Sale
Common Stock
2025-08-18$50.94/sh−1,973$100,512→ 463,318 total - Tax Payment
Common Stock
2025-08-16$51.32/sh−21,317$1,093,988→ 480,671 total - Sale
Common Stock
2025-08-18$50.14/sh−15,380$771,210→ 465,291 total
Footnotes (4)
- [F1]Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 38,547 shares of Common Stock underlying the Reporting Person's Restricted Stock Units.
- [F2]This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.
- [F3]Represents the weighted average sale price of the shares sold from $49.76 to $50.75 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
- [F4]Represents the weighted average sale price of the shares sold from $50.83 to $50.95 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
Documents
Issuer
BridgeBio Pharma, Inc.
CIK 0001743881
Entity typeother
Related Parties
1- filerCIK 0002030813
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 7:40 PM ET
- Size
- 8.7 KB